Home | Welcome to Contract Pharma   
Last Updated Tuesday, September 30 2014
Print

Breaking News

Gil Roth
January 30, 2014
Service revenues rise across the board, with 30% bump for Perceptive Informatics unit  Read More »
Kristin Brooks
January 30, 2014
$5 mil expansion provides lab space, instrumentation to support growth  Read More »
Gil Roth
January 30, 2014
Soliris sales continue to climb  Read More »
Gil Roth
January 30, 2014
Cymbalta expiration begins to weigh down sales  Read More »
Kristin Brooks
January 29, 2014
To conduct Phase II trial of NurOwn in ALS  Read More »
Kristin Brooks
January 29, 2014
To produce a new class of APIs called viral vectors   Read More »
Kristin Brooks
January 29, 2014
To provide development and commercialization services for CicloMulsion  Read More »
Kristin Brooks
January 29, 2014
Adds biologics expertise and significant U.S. presence  Read More »
Kristin Brooks
January 29, 2014
Pharma sales up 1% in the quarter, benefits from delayed Diovan generic in the U.S.  Read More »
Kristin Brooks
January 29, 2014
Product sales up 11% in the quarter  Read More »
Kristin Brooks
January 29, 2014
Expanded MS franchise drives growth  Read More »
Kristin Brooks
January 28, 2014
Out-licenses test to Precision Therapeutics   Read More »
Kristin Brooks
January 28, 2014
Cross to spearhead investments in Metrics ops  Read More »
Kristin Brooks
January 28, 2014
Taylor given “Young Achiever Accolade” in Pharma category  Read More »
Kristin Brooks
January 28, 2014
Maimonis to lead development and commercialization of assays for Phase III cancer drug  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On